Biotest AG (BIOG_p.DE)
BIOG_p.DE on Xetra
26.50EUR
25 Apr 2018
26.50EUR
25 Apr 2018
Change (% chg)
€-0.20 (-0.75%)
€-0.20 (-0.75%)
Prev Close
€26.70
€26.70
Open
€26.70
€26.70
Day's High
€26.70
€26.70
Day's Low
€26.30
€26.30
Volume
9,451
9,451
Avg. Vol
33,234
33,234
52-wk High
€27.70
€27.70
52-wk Low
€17.90
€17.90
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- ownership
- filings
- deals
- private equity
- third-party document and information retrieval
- estimates
- fundamentals
- economics
- events
- news
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
Name | Age | Since | Current Position |
---|---|---|---|
Rolf Hoffman |
58 | 2017 | Chairman of the Supervisory Board |
Bernhard Ehmer |
63 | 2015 | Chairman of the Management Board |
Cathrin Schleussner |
2004 | Deputy Chairperson of the Supervisory Board | |
Michael Ramroth |
56 | 2004 | Chief Financial Officer, Member of the Board of Management |
Martin Moeller |
Group Finance and Treasury Officer |
- BRIEF-Biotest Fy 2017 EBIT Turns To Profit Of Eur 18.0 Mln
- German stocks - Factors to watch on March 22
- BRIEF-Biotest: First Patient With Acquired Fibrinogen Deficiency Treated In Clinical Phase III Study
- BRIEF-Biotest Supports Study On Use Of Pentaglobin In Patients With Severe Bacterial Infections
- BRIEF-Biotest FY Revenue Falls To EUR 378.1 Mln On Recall Of Human Albumin